The safer live MG vaccine
Nobilis MG 6/85 is a live freeze-dried vaccine for the active immunization of chickens to reduce clinical signs of infection with
Mycoplasma gallisepticum.
The vaccine contains at least 10
7 CFU per dose of the MG 6/85 strain of
Mycoplasma gallisepticum.
The benefits of Nobilis MG 6/85 are as follows:
- The MG6/85 strain is genetically stable and non-pathogenic for chickens and turkeys.
- Nobilis MG 6/85 is a freeze dried vaccine, suitable for conventional vaccine storage (2 - 8 °C) and handling.
- Convenient mass administration by fine spray.
- Nobilis MG 6/85 prevents Mycoplasma gallisepticum related drops in egg production.
- Generally Nobilis MG 6/85 does not induce seroconversion using the SPA-test in layer pullets, thus it is possible to continue monitoring flocks for field infections. In rare cases some SPA reactions can be observed.
Description
Nobilis MG 6/85 is a live vaccine for the active immunization of chickens to reduce clinical signs of
infection with Mycoplasma gallisepticum.
Composition
Active components per dose:
- Live M. gallisepticum strain 6/85: ≥ 106.9 CFU.
Formulation
A freeze-dried pellet.
Target species
Chickens (future layers).
Indications
Active immunization of future layers to reduce the clinical signs of Mycoplasma gallisepticum infection.
Vaccination programme
The vaccine is administered as a single dose to chickens of six weeks of age or older.
Dosage
One dose per bird.
Method of administration
To be fully effective, the vaccine must be administered by aerosol to healthy, receptive animals
maintained in a proper environment under good management.
Withholding period
None.
Presentation
Boxes of vials each containing 1000 doses.
Storage
Store between 2-8°C in the dark.
Precautions
- Wash and disinfect hands and equipment after vaccination.
- Vaccinate only healthy birds.
- Each vial should be used immediately after opening.
Contra-indications and Warning
- Do not administer this vaccine within four weeks of the onset of lay or to laying birds.
A minimum interval of two weeks must be allowed between the use of this vaccine and other vaccines
against diseases of the respiratory tract (for example Newcastle Disease, Infectious Bronchitis etc.).
- Do not medicate birds with any antibacterial drugs, especially those with anti-mycoplasma activity,
during the five days prior to or two weeks following vaccination.
- Do not use other vaccines within 14 days.
Further information
- For animal treatment only.
- All susceptible birds on the same premises should be vaccinated at the same time.
- Efforts should be made to reduce stress during and immediately after vaccination.
- Do not mix this vaccine with any substance.
- Do not dilute this vaccine, or attempt to extend the number of doses from one vial.
- Use entire contents when first opened.
- Do not store partly used containers for further use.
- It is good vaccination practice when handling the vaccine to avoid contact with eyes, hands and clothing.
- Keep out of the reach of children.
- The 6/85 strain of MG is not pathogenic to turkeys, but care should be taken in using the vaccine and
handling chickens, so as to maintain very tight disease security.
- Dispose of empty or part-used vials in accordance with local regulations.
Publication date: 1st June 2005